Critical considerations for public engagement in stem cell-related research
Authors:
- 2 February 2023
- journal article
- editorial
- Published by Elsevier in Stem Cell Reports
- Vol. 18 (2) , 420-426
Abstract
No abstract availableKeywords
Funding Information
- Merck KGaA
- International Society for Stem Cell Research
- New York Stem Cell Foundation
- World Health Organization
- National Stem Cell Foundation of Australia
This publication has 15 references indexed in Scilit:
- Operationalizing Human Immunodeficiency Virus Cure-related Trials with Analytic Treatment Interruptions During the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic: A Collaborative ApproachClinical Infectious Diseases, 2020
- Australian Regulation of Autologous Human Cell and Tissue Products: Implications for Commercial Stem Cell ClinicsRegenerative Medicine, 2020
- A collaborative, multidisciplinary approach to HIV transmission risk mitigation during analytic treatment interruptionJournal of Virus Eradication, 2020
- Mitochondrial replacement therapy: the UK and US regulatory landscapesJournal of Law and the Biosciences, 2016
- Regulatory Loophole Enables Unproven Autologous Cell Therapies to Thrive in AustraliaStem Cells and Development, 2014
- Why should we promote public engagement with science?Public Understanding of Science, 2014
- Tracking and assessing the rise of state-funded stem cell researchNature Biotechnology, 2010
- New ISSCR Guidelines Underscore Major Principles for Responsible Translational Stem Cell ResearchCell Stem Cell, 2008
- Stem Cell Clinics Online: The Direct-to-Consumer Portrayal of Stem Cell MedicineCell Stem Cell, 2008
- Stem cell therapy or snake oil?Nature Biotechnology, 2005